A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 580 participants.

Also called NCT05582395

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 580 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05582395
  • WHO UTN U1111-1269-8581
  • EudraCT 2023-506352-24
Other papers using this trial's data
  • Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy: Insights From the ODYSSEY-HCM Trial Journal of the American College of Cardiology, 2025-12-16 DOI, PubMed 40864018
  • Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy The New England journal of medicine, 2025-09-11 DOI, PubMed 40888717

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, Denmark, France, Germany, Hungary, India, Israel, Italy, Japan, Netherlands, Norway, Poland, Portugal, South Korea, Spain, United Kingdom (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT05582395. Randomized; double masking; primary purpose treatment. Start 2022-12-14 (actual); primary completion 2025-03-06 (actual). Results posted on 2026-08-20.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
Acronym
ODYSSEY-HCM
Condition
Cardiomyopathy, Hypertrophic
Intervention (Drug)
Mavacamten
Intervention (Other)
Placebo
Lead sponsor
Bristol-Myers Squibb (class: industry)

Record details

Record id
cardio:ct-nct05582395
Content hash
309e235e57ac4abd803db3ddc1921c47911d6169313da4311d1b03003f782d6e